Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Gross Margin Growth (3y) (2012 - 2026)

Analysis

Charles River Laboratories International (CRL) Gross Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -162.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 153.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -601.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 738.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -104.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 1,393.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 1,171.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 944.00
10 VivoSim Labs 1.37 Mn 1.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 738.00
Mar 28, 2026 217.00
Dec 27, 2025 -348.00
Sep 27, 2025 -333.00
Jun 28, 2025 -296.00
Mar 29, 2025 -540.00
Dec 28, 2024 1,722.00
Sep 28, 2024 -1,313.00
Jun 29, 2024 -1,340.00
Mar 30, 2024 -1,449.00
Dec 30, 2023 2,018.00
Sep 30, 2023 -1,400.00
Jul 1, 2023 -743.00
Apr 1, 2023 -1,058.00
Dec 31, 2022 -309.00
Sep 24, 2022 -97.00
Jun 25, 2022 -118.00
Mar 26, 2022 -87.00
Dec 25, 2021 -81.00
Sep 25, 2021 -139.00